Intravenous Beta-Blockade for Limiting Myocardial Infarct Size Rejuvenation of a Concept

Journal of the American College of Cardiology

Volumn 67, Issue 18, 2016, Pages 2105-2107

  Kloner, Robert A ^a,b   Braunwald, Eugene ^c,d  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

cardioprotection; metoprolol; myocardial infarct size; myocardial ischemia reperfusion; ST segment elevation myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE; ESMOLOL; METOPROLOL; TIMOLOL;

CARDIOVASCULAR MAGNETIC RESONANCE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HUMAN; NONHUMAN; NOTE; OXYGEN CONSUMPTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; TREATMENT DURATION; REJUVENATION;

HUMANS; METOPROLOL; MYOCARDIAL INFARCTION; REJUVENATION;

EID: 84962090045     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.02.061     Document Type: Editorial

References (30)

1. J. Lenberg, N. Vejlstrup, H. Kelbaek, and et al. Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: an observational study Eur Heart J Cardiovasc Imaging 14 2013 387 395
2. P.Z. Gerczuk, and R.A. Kloner An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarct size in clinical trials J Am Coll Cardiol 59 2012 969 978
3. B. Ibanez, C. Macaya, V. Sanchez-Brunete, and et al. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial Circulation 128 2013 1495 1503
4. E. Braunwald, J.W. Covell, P.R. Maroko, and J. Ross Jr. Effects of drugs and of counterpulsation on myocardial oxygen consumption Circulation 40 Suppl IV 1969 220 228
5. P.R. Maroko, J.K. Kjekshus, B.E. Sobel, and et al. Factors influencing infarct size following experimental coronary artery occlusions Circulation 43 1971 67 82
6. K.A. Reimer, M.M. Rasmussen, and R.B. Jennings Reduction by propranolol of myocardial necrosis following temporary coronary occlusion in dogs Circ Res 33 1973 353 363
7. M.M. Rasmussen, K.A. Reimer, R.A. Kloner, and et al. Infarct size reduction by propranolol before and after coronary ligation in dogs Circulation 56 1977 794 798
8. L.D. Hillis, S.F. Khuri, E. Braunwald, and et al. Assessment of the efficacy of interventions to limit ischemic injury by direct measurement of intramural carbon dioxide tension after coronary occlusion in the dog J Clin Invest 63 1979 99 107
9. R.A. Kloner, M.C. Fishbein, E. Braunwald, and et al. Effect of propranolol on mitochondrial morphology during acute myocardial ischemia Am J Cardiol 41 1978 880 886
10. R.A. Kloner, M.C. Fishbein, R.A. Cotran, and et al. The effect of propranolol on microvascular injury in acute myocardial ischemia Circulation 55 1977 872 880
11. H. Hammerman, R.A. Kloner, L.L. Briggs, and et al. Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol) Am J Cardiol 3 1984 1438 1443
12. R. Lange, R.A. Kloner, and E. Braunwald First ultra-short-acting beta-adrenergic blocking agent: its effect on size and segmental wall dynamics of reperfused myocardial infarcts in dogs Am J Cardiol 51 1983 1759 1767
13. R. Lange, M.S. Nieminen, and R.A. Kloner Failure of pindolol and metoprolol to reduce the size of non-reperfused infarcts in dogs using area at risk techniques Cardiovasc Res 18 1984 37 43
14. S. Yusuf, D. Ramsdale, R. Peto, and et al. Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomized trial Lancet 2 1980 273 276
15. F. Roque, L.M. Amuchastegui, M.A. Lopez Morillos, and et al. Beneficial effects of timolol on infarct size and late ventricular tachycardia in patients with acute myocardial infarction Circulation 76 1987 610 617
16. R. Roberts, C. Croft, H.K. Gold, and et al. Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial N Engl J Med 311 1984 218 225
17. M. Pfisterer, J.L. Cox, C.B. Granger, and et al. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-1 experience. Global Utilization of Streptokinase and TPA (altepase) for Occluded Coronary Arteries J Am Coll Cardiol 32 1998 634 640
18. R. Roberts, W.J. Rogers, H.S. Mueller, and et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study Circulation 83 1991 422 437
19. P. O'Gara, F.G. Kushner, D.D. Ascheim, and et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction J Am Coll Cardiol 61 2013 e78 e140
20. E.R. Bates Role of intravenous β-blockers in the treatment of ST-elevation myocardial infarction of mice (dogs, pigs) and men Circulation 115 2007 2904 2906
21. N. Freemantle, J. Cleland, P. Young, J. Mason, and J. Harrison Beta blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737
22. B. Ibáñez, S. Prat-Gonzalez, W.S. Speidl, and et al. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage. Analysis of ischemic myocardium at risk using cardiac magnetic resonance Circulation 115 2007 2909 2916
23. G. Pizarro, L. Fernandez-Friera, V. Fuster, and et al. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction) J Am Coll Cardiol 63 2014 2356 2362
24. J.M. García-Ruiz, R. Fernández-Jiménez, A. García-Alvarez, and et al. Impact of the timing of metoprolol administration during STEMI on infarct size and ventricular function J Am Coll Cardiol 67 2016 2093 2104
25. A. Mateos, I. Garcia-Lunar, J.M. Garcia-Ruiz, and et al. Efficacy and safety of out-of-hospital intravenous metoprolol administration in anterior ST-segment elevation acute myocardial infarction: insights from the METOCARD-CNIC trial Ann Emerg Med 65 2015 318 324
26. S.L. Hale, and R.A. Kloner Myocardial temperature in acute myocardial infarction: protection with mild regional hypothermia Am J Physiol Heart Circ Physiol 273 1 pt 2 1997 H220 H227
27. S.L. Hale, M.J. Herring, and R.A. Kloner Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size J Am Heart Assoc 2 2013 e004234
28. M.J. Herring, S.L. Hale, W. Dai, and et al. Hypothermia in the setting of experimental acute myocardial infarction: a comprehensive review Ther Hypothermia Temp Manag 4 2014 159 167
29. E. Fikert, K.M. Dahlem, A.M. Nia, and et al. Randomized control of sympathetic drive with continuous intravenous esmolol in patients with acute ST-segment elevation myocardial infarction. The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial J Am Coll Cardiol Intv 9 2016 231 240
30. S. Sattar, S.J. Brener, G.W. Stone, and et al. Pharmacologic therapy for reducing myocardial infarct size in clinical trials: failed and promising approaches J Cardiovasc Pharmacol Ther 20 2015 21 35